Treatment is aimed at controlling disease, relieving symptoms and complications, extending and improving the quality of life, and, ultimately, cure.
Each patient’s personalized treatment plan is based on a number of factors, including age, overall health, clinical laboratory and imaging results, specialized genetic diagnostic testing results, and prior treatment.
Treatment may or may not include combinations of chemotherapy, bone-strengthening drugs, immunotherapy, and stem cell transplantation. The Myeloma Institute’s team of specialists is constantly developing new, innovative treatments with maximum effectiveness and minimal side effects that target malignant cells but spare healthy cells.
Our goal is to harness the power of biological understanding for the best possible outcome. Learn more about some of our treatment approaches below.